Daily News Podcast

Statin effect in prostate cancer may be caused by reduced inflammation


 

Long-term use of statins may protect against lethal forms of prostate cancer by altering the inflammatory profile of the tumor microenvironment. Also today, Verma unveils Medicaid scorecard but refuses to judge efforts, the AMA reports that opioid prescriptions are down since 2013, and a prior knee injury creates a ‘distinct group’ in osteoarthritis.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

MDedge Daily News: Genes, not adiposity, may be driving appetite differences in obesity
MDedge Rheumatology
Peer mentorship, groups help combat burnout in female physicians
MDedge Rheumatology
MDedge Daily News: Group support, mentorship help combat burnout in female physicians
MDedge Rheumatology
Psoriasis therapy with biologics not linked to increased cancer risk
MDedge Rheumatology
High testosterone in postmenopausal women may add CVD risk
MDedge Rheumatology
ACS: Screen for colon cancer at 45
MDedge Rheumatology
TAILORx: Most women with intermediate risk ER+ breast cancer can safely skip chemo
MDedge Rheumatology
Hydroxychloroquine throws off Quantiferon-TB Gold results, study finds
MDedge Rheumatology
Hip pain predicts arthritis mortality beyond comorbidities
MDedge Rheumatology
Prostate cancer risk before age 55 higher for black men
MDedge Rheumatology